Caxton Associates (New York)’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,562
| Closed | -$111K | – | 535 |
|
|
2023
Q4 | $111K | Buy |
+11,562
| New | +$111K | 0.01% | 442 |
|
|
2023
Q3 | – | Sell |
-13,838
| Closed | -$74K | – | 536 |
|
|
2023
Q2 | $74K | Sell |
13,838
-106,930
| -89% | -$572K | 0.01% | 465 |
|
|
2023
Q1 | $866K | Sell |
120,768
-70,589
| -37% | -$506K | 0.13% | 168 |
|
|
2022
Q4 | $1.28M | Sell |
191,357
-92,031
| -32% | -$618K | 0.09% | 68 |
|
|
2022
Q3 | $981K | Buy |
283,388
+265,779
| +1,509% | +$920K | 0.13% | 107 |
|
|
2022
Q2 | $52K | Buy |
+17,609
| New | +$52K | 0.01% | 515 |
|